{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:37:02Z","timestamp":1788511022860,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2023YFA1801100"],"award-info":[{"award-number":["2023YFA1801100"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870610"],"award-info":[{"award-number":["81870610"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171177"],"award-info":[{"award-number":["32171177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92057106"],"award-info":[{"award-number":["92057106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92357307"],"award-info":[{"award-number":["92357307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019794","name":"Institute of Genetics and Developmental Biology, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science Bulletin"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.scib.2023.12.053","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T12:39:53Z","timestamp":1704199193000},"page":"1920-1935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Ethanolamine as a biomarker and biomarker-based therapy for diabetic retinopathy in glucose-well-controlled diabetic patients"],"prefix":"10.1016","volume":"69","author":[{"given":"Guangyi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhi","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangjia","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxue","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunqi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scib.2023.12.053_b0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.survophthal.2012.01.004","article-title":"Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective","volume":"57","author":"Sivaprasad","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.scib.2023.12.053_b0010","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic Review and Meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.scib.2023.12.053_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.scib.2023.12.053_b0020","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1167\/iovs.16-21031","article-title":"Diabetic retinopathy: Battling the global epidemic","volume":"57","author":"Das","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.scib.2023.12.053_b0025","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1001\/jama.2010.785","article-title":"Beyond hemoglobin A1c\u2013need for additional markers of risk for diabetic microvascular complications","volume":"303","author":"Hirsch","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.scib.2023.12.053_b0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200002103420603","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy, by The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","volume":"342","author":"Barr","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.scib.2023.12.053_b0035","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1464-5491.2001.00458.x","article-title":"Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)","volume":"18","author":"Kohner","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.scib.2023.12.053_b0040","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/jama.298.8.902","article-title":"Management of diabetic retinopathy: A systematic review","volume":"298","author":"Mohamed","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.scib.2023.12.053_b0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.scib.2023.12.053_b0050","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Group","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scib.2023.12.053_b0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1464-5491.2009.02870.x","article-title":"Diabetic retinopathy screening: A systematic review of the economic evidence","volume":"27","author":"Jones","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.scib.2023.12.053_b0060","first-page":"11","article-title":"Metabolomics in diabetic retinopathy: from potential biomarkers to molecular basis of oxidative stress","author":"Jian","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.scib.2023.12.053_b0065","first-page":"12","article-title":"Integrated metabolomics and transcriptomics reveal metabolic patterns in retina of STZ-induced diabetic retinopathy mouse model","author":"Wang","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.scib.2023.12.053_b0070","first-page":"12","article-title":"Amino acids metabolism in retinopathy: from clinical and basic research perspective","author":"Xia","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.scib.2023.12.053_b0075","article-title":"Branched-chain amino acids metabolism and their roles in retinopathy: from relevance to mechanism","volume":"15","author":"Zhang","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.scib.2023.12.053_b0080","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202001714","article-title":"Multiplatform metabolomics reveals novel serum metabolite biomarkers in diabetic retinopathy subjects","volume":"7","author":"Xuan","year":"2020","journal-title":"Adv Sci"},{"key":"10.1016\/j.scib.2023.12.053_b0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.visres.2017.04.003","article-title":"The pathology associated with diabetic retinopathy","volume":"139","author":"Lechner","year":"2017","journal-title":"Vision Res"},{"key":"10.1016\/j.scib.2023.12.053_b0090","first-page":"2","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.scib.2023.12.053_b0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00592-019-01363-0","article-title":"Metabolomic profile of diabetic retinopathy: A GC-TOFMS-based approach using vitreous and aqueous humor","volume":"57","author":"Wang","year":"2020","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.scib.2023.12.053_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11306-015-0877-5","article-title":"Global metabolomics reveals metabolic dysregulation in ischemic retinopathy","volume":"12","author":"Paris","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.scib.2023.12.053_b0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1878-5085-4-7","article-title":"Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine","volume":"4","author":"Drucker","year":"2013","journal-title":"EPMA J"},{"key":"10.1016\/j.scib.2023.12.053_b0110","doi-asserted-by":"crossref","DOI":"10.1177\/1177271917715236","article-title":"Making meaningful clinical use of biomarkers","volume":"12","author":"Selleck","year":"2017","journal-title":"Biomark Insights"},{"key":"10.1016\/j.scib.2023.12.053_b0115","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1815111","article-title":"Serine and lipid metabolism in macular disease and peripheral neuropathy","volume":"381","author":"Gantner","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scib.2023.12.053_b0120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000501372","article-title":"ETDRS grading of diabetic retinopathy: Still the gold standard?","volume":"62","author":"Solomon","year":"2019","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.scib.2023.12.053_b0125","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/1753-0407.13118","article-title":"Lower free thyroid hormone levels are associated with high blood glucose and insulin resistance; these normalize with metabolic improvement of type 2 diabetes","volume":"13","author":"Gu","year":"2021","journal-title":"J Diabetes"},{"key":"10.1016\/j.scib.2023.12.053_b0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1753-0407.12847","article-title":"Metabolic Management Center: An innovation project for the management of metabolic diseases and complications in China","volume":"11","author":"Zhang","year":"2019","journal-title":"J Diabetes"},{"key":"10.1016\/j.scib.2023.12.053_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108490","article-title":"Microglia increase tight-junction permeability in coordination with M\u00fcller cells under hypoxic condition in an in vitro model of inner blood-retinal barrier","volume":"205","author":"Inada","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.scib.2023.12.053_b0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00125-020-05299-x","article-title":"Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src\/Akt\/cofilin signalling in experimental diabetic retinopathy","volume":"64","author":"Xie","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.scib.2023.12.053_b0145","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1167\/iovs.16-20718","article-title":"Organotypic cultures of adult mouse retina: morphologic changes and gene expression","volume":"58","author":"Muller","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.scib.2023.12.053_b0150","first-page":"9","article-title":"Effect of topical administration of somatostatin on retinal inflammation and neurodegeneration in an experimental model of diabetes","author":"Hern\u00e1ndez","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.scib.2023.12.053_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010110","article-title":"The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration","volume":"19","author":"Altmann","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.scib.2023.12.053_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19040942","article-title":"Role of Inflammation in diabetic retinopathy","volume":"19","author":"Rubsam","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.scib.2023.12.053_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.564077","article-title":"Microglia and inflammatory responses in diabetic retinopathy","volume":"11","author":"Kinuthia","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.scib.2023.12.053_b0170","article-title":"Integrated multi-omics reveals the activated retinal microglia with intracellular metabolic reprogramming contributes to inflammation in STZ-induced early diabetic retinopathy","volume":"13","author":"Lv","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.scib.2023.12.053_b0175","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1734-1140(09)70111-2","article-title":"Role of NF-kappa B in the pathogenesis of diabetes and its associated complications","volume":"61","author":"Patel","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.scib.2023.12.053_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells5010012","article-title":"The regulation of NF-kappaB subunits by phosphorylation","volume":"5","author":"Christian","year":"2016","journal-title":"Cells"},{"key":"10.1016\/j.scib.2023.12.053_b0185","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2337\/db20-0104","article-title":"Circulating metabolites and lipids are associated to diabetic retinopathy in individuals with Type 1 diabetes","volume":"69","author":"Curovic","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.scib.2023.12.053_b0190","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.152109","article-title":"Diminished retinal complex lipid synthesis and impaired fatty acid beta-oxidation associated with human diabetic retinopathy","volume":"6","author":"Fort","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.scib.2023.12.053_b0195","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/iub.337","article-title":"The Kennedy pathway\u2013De novo synthesis of phosphatidylethanolamine and phosphatidylcholine","volume":"62","author":"Gibellini","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.scib.2023.12.053_b0200","doi-asserted-by":"crossref","first-page":"23636","DOI":"10.1074\/jbc.M803600200","article-title":"Phosphatidylethanolamine in Trypanosoma brucei is organized in two separate pools and is synthesized exclusively by the Kennedy pathway","volume":"283","author":"Signorell","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.scib.2023.12.053_b0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12944-020-01286-8","article-title":"Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review","volume":"19","author":"Kolczynska","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.scib.2023.12.053_b0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/157339907779802139","article-title":"Leukocytes in diabetic retinopathy","volume":"3","author":"Chibber","year":"2007","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.scib.2023.12.053_b0215","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/dc16-1974","article-title":"Type 2 diabetes in the real world: the elusive nature of glycemic control","volume":"40","author":"Edelman","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.scib.2023.12.053_b0220","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years","volume":"102","author":"Klein","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.scib.2023.12.053_b0225","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jdiacomp.2008.02.012","article-title":"Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients","volume":"23","author":"Romero-Aroca","year":"2009","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.scib.2023.12.053_b0230","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4239\/wjd.v2.i6.98","article-title":"Managing diabetic macular edema: the leading cause of diabetes blindness","volume":"2","author":"Romero-Aroca","year":"2011","journal-title":"World J Diabetes"},{"key":"10.1016\/j.scib.2023.12.053_b0235","doi-asserted-by":"crossref","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the Human Metabolome Database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.scib.2023.12.053_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11090614","article-title":"Novel serum and urinary metabolites associated with diabetic retinopathy in three Asian cohorts","volume":"11","author":"Quek","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.scib.2023.12.053_b0245","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1167\/iovs.19-27321","article-title":"Arginine and Carnitine metabolites are altered in diabetic retinopathy","volume":"60","author":"Sumarriva","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.scib.2023.12.053_b0250","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2337\/dc09-0816","article-title":"Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines","volume":"32","author":"Abhary","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.scib.2023.12.053_b0255","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00395-010-0125-0","article-title":"Ethanolamine is a novel STAT-3 dependent cardioprotective agent","volume":"105","author":"Kelly","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.scib.2023.12.053_b0260","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1073\/pnas.79.4.1158","article-title":"Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component","volume":"79","author":"Murakami","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.scib.2023.12.053_b0265","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/JOE-17-0109","article-title":"Cysteamine prevents vascular leakage through inhibiting transglutaminase in diabetic retina","volume":"235","author":"Lee","year":"2017","journal-title":"J Endocrinol"},{"key":"10.1016\/j.scib.2023.12.053_b0270","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archophthalmol.2007.65","article-title":"Microglial activation in human diabetic retinopathy","volume":"126","author":"Zeng","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.scib.2023.12.053_b0275","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-kappaB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.scib.2023.12.053_b0280","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.scib.2023.12.053_b0285","first-page":"1624","article-title":"Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice","volume":"40","author":"Yoshida","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.scib.2023.12.053_b0290","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.ircmb.2015.10.001","article-title":"Phosphatidylethanolamine metabolism in health and disease","volume":"321","author":"Calzada","year":"2016","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.scib.2023.12.053_b0295","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1139\/O07-006","article-title":"Metabolic and molecular aspects of ethanolamine phospholipid biosynthesis: the role of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2)","volume":"85","author":"Bakovic","year":"2007","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.scib.2023.12.053_b0300","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000489504","article-title":"Unique Francisella Phosphatidylethanolamine acts as a potent anti-inflammatory lipid","volume":"10","author":"Ireland","year":"2018","journal-title":"J Innate Immun"},{"key":"10.1016\/j.scib.2023.12.053_b0305","doi-asserted-by":"crossref","first-page":"21185","DOI":"10.1074\/jbc.M109.021634","article-title":"Phosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease","volume":"284","author":"Morgan","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.scib.2023.12.053_b0310","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1074\/jbc.M115.706523","article-title":"Phosphatidylethanolamine is a key regulator of membrane fluidity in eukaryotic cells","volume":"291","author":"Dawaliby","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.scib.2023.12.053_b0315","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/bi051809x","article-title":"Interactions between phospholipids and NADH:ubiquinone oxidoreductase (complex I) from bovine mitochondria","volume":"45","author":"Sharpley","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.scib.2023.12.053_b0320","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00592-017-0984-z","article-title":"Modulation of microglia in the retina: new insights into diabetic retinopathy","volume":"54","author":"Arroba","year":"2017","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.scib.2023.12.053_b0325","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1189\/jlb.0608385","article-title":"Microglia: gatekeepers of central nervous system immunology","volume":"85","author":"Tambuyzer","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.scib.2023.12.053_b0330","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.scib.2023.12.053_b0335","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/1566524017666170331161715","article-title":"Ethanolamine metabolism in the mammalian gastrointestinal tract: mechanisms, patterns, and importance","volume":"17","author":"Zhou","year":"2017","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.scib.2023.12.053_b0340","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0041-008X(77)90019-9","article-title":"Acute toxicity and skin corrosion data for some organic and inorganic compounds and aqueous solutions","volume":"42","author":"Vernot","year":"1977","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.scib.2023.12.053_b0345","first-page":"119","article-title":"Range-finding toxicity data: List IV","volume":"4","author":"Smyth","year":"1951","journal-title":"AMA Arch Ind Hyg Occup Med"}],"container-title":["Science Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927323009398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927323009398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:40:58Z","timestamp":1778838058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095927323009398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2095927323009398"],"URL":"https:\/\/doi.org\/10.1016\/j.scib.2023.12.053","relation":{},"ISSN":["2095-9273"],"issn-type":[{"value":"2095-9273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethanolamine as a biomarker and biomarker-based therapy for diabetic retinopathy in glucose-well-controlled diabetic patients","name":"articletitle","label":"Article Title"},{"value":"Science Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scib.2023.12.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Science China Press. Published by Elsevier B.V. and Science China Press.","name":"copyright","label":"Copyright"}]}}